Evidence map›Paper›PMID 36448018›Full record

ArticleMicrobial cell (Graz, Austria)2022

Multiple genome analysis of

Pedro Pais, Mónica Galocha, Azusa Takahashi-Nakaguchi, Hiroji Chibana, Miguel C Teixeira

Open access · goldAbstract read
In one paragraph

Article in Microbial cell (Graz, Austria), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Journal of medical microbiology · 2026
    Review
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Microbiology and molecular biology reviews : MMBR · 2024
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Pedro PaisDepartment of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Mónica GalochaDepartment of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Azusa Takahashi-NakaguchiMedical Mycology Research Center (MMRC), Chiba University, Chiba, Japan.
Hiroji ChibanaMedical Mycology Research Center (MMRC), Chiba University, Chiba, Japan.
Miguel C TeixeiraDepartment of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
University of Lisbon · PTChiba University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of drug resistance significantly hampers the treatment of human infections, including those caused by fungal pathogens such as

Indexed as

Candida glabrataclinical isolatesCNVdrug resistancegenome variationSNP

Identifiers

PMID36448018
PMCPMC9662024
OpenAlexW4308438537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.